Bifunctional Fluorinated Separator Enabling Polysulfide Trapping and Li Deposition for Lithium-Sulfur Batteries

Lithium-sulfur batteries (LSBs) are deemed as one of the most promising next generation energy storage system substitutes for conventional lithium ion batteries due to their high energy density, low cost, and environmental friendliness. The practical application of LSBs has long been blocked by the serious lithium polysulfide (LiPS) shuttle effect and notorious Li dendrite growth, inducing fast capacity decay and limited cycling lifespan. Herein, fluorinated carbon prepared via a safe and scalable strategy has rationally been coated on a separator affording bifunctional fluorinated Celgard (F-Celgard) for LSB construction. The F-Celgard shows superior Li⁺ flux modulation and LiPS trapping capability, which has been verified by the density function theory calculations. The Li symmetric cells demonstrate long and stable Li plating/stripping with much smaller polarization voltage and dendrite-free Li deposition. In addition, LSBs show superior rate performances with higher discharge capacities and long-time stable cycling over 1000 cycles at 1 C with a low decay rate of ∼0.038% per cycle. With a high sulfur loading (∼5.2 mg cm^-2), a high initial areal capacity of ∼4.2 mAh cm^-2 can be obtained with a superior capacity retention of ∼91.8% at 0.2 C. This work demonstrates a facile, cost-effective, and scalable strategy toward highly stable LSBs for practical usage.

Investigation on Fabrication of Reduced Graphene Oxide-Sulfur Composite Cathodes for Li-S Battery via Hydrothermal and Thermal Reduction Methods

Lithium-sulfur (Li-S) battery is considered one of the possible alternatives for next-generation high energy batteries. However, its practical applications are still facing great challenges because of poor electronic conductivity, large volume change, and polysulfides dissolution inducing “shuttle reaction” for the S cathode. Many strategies have been explored to alleviate the aforementioned concerns. The most common approach is to embed S into carbonaceous matrix for constructing C-S composite cathodes. Herein, we fabricate the C-S cathode reduced graphene oxide-S (rGO-S) composites via one step hydrothermal and in-situ thermal reduction methods. The structural features and electrochemical properties in Li-S cells of the two type rGO-S composites are studied systematically. The rGO-S composites prepared by one step hydrothermal method (rGO-S-HT) show relatively better comprehensive performance as compared with the ones by in-situ thermal reduction method (rGO-S-T). For instance, with a current density of 100 mA g⁻¹, the rGO-S-HT composite cathodes possess an initial capacity of 1290 mAh g⁻¹ and simultaneously exhibit stable cycling capability. In particular, as increasing the current density to 1.0 A g⁻¹, the rGO-S-HT cathode retains a reversible capacity of 582 mAh g⁻¹ even after 200 cycles. The enhanced electrochemical properties can be attributed to small S particles uniformly distributed on rGO sheets enabling to significantly improve the conductivity of S and effectively buffer large volume change during lithiation/delithiation.

MicroRNA-26b-5p alleviates cerebral ischemia-reperfusion injury in rats via inhibiting the N-myc/PTEN axis by downregulating KLF10 expression

MicroRNAs plays important role in cerebral ischemia-reperfusion (CIR). However, the role of miR-26b-5p in CIR injury remains unclear. PC12 cells were treated with oxygen-glucose deprivation (OGD) for 0 h, 2 h, 4 h, 6 h, and then reoxygenated for 24 h to construct an in vitro I/R model. Then, miR-26b-5p mimic, small interfering RNA of KLF10 and KLF10 overexpression plasmid were transfected into cells respectively for mechanism study. Our results showed that miR-26b-5p was downregulated in OGD/R-induced PC12 cells. After overexpression of miR-26b-5p, cell proliferation ability was enhanced, apoptosis, ROS and inflammatory mediators were inhibited. Bioinformatics analysis indicated that miR-26b-5p was directly bound to the 3' UTR of KLF10, and downregulated the expression of KLF10. KLF10 was upregulated in OGD/R cells, and transfection with si-KLF10 promoted cell proliferation and reduced apoptosis, NO concentration and inflammatory factor secretion. Moreover, pcDNA-KLF10 reversed the inhibitory effects of miR-26b-5p mimic on apoptosis, NO content and inflammatory factor secretion, as well as the downregulation of N-myc and PTEN expression. Meanwhile, I/R rat models were constructed and divided into sham operation group (femoral artery isolation only), model group (middle cerebral artery occlusion model of rats was prepared by thread embolization), treatment group (200 µL of miR-26b-5p mimic was injected into the brain of model rats). We observed that the infarct size of brain tissue was reduced, KLF10 expression was downregulated, and apoptosis and inflammatory response were reduced. These results suggest that miR-26b-5p had protective effects on CIRI and it may be a potential treatment target.

Multielement synergetic effect of NiFe2O4 and h-BN for improving the dehydrogenation properties of LiAlH4

NiFe₂O₄@h-BN composites significantly improved the dehydrogenation and rehydrogenation properties of LiAlH₄. The Al₄Ni₃ and LiFeO₂ found in doped LiAlH₄, and Al_1.1Ni_0.9 in the process of heating, improved the dehydrogenation properties of LiAlH₄.

Highly Stable and Ultrahigh-Rate Li Metal Anode Enabled by Fluorinated Carbon Fibers

The advanced energy storage of an Li metal substituted for graphite anode can provide a significant enhancement in a battery's energy density. Nevertheless, the practical implementation of metallic Li has seriously been fettered by the notorious Li dendrite growth and the huge volumetric variation of Li metal inducing poor cycling performance and safety concerns. In this regard, constructing a robust SEI layer combined with a 3D host to stabilize the Li metal is strongly in demand. Herein, a highly stable hosted Li with an LiF dominated SEI has successfully been achieved through metal-free fluorinated carbon fibers (FCF) with strong lithiophilicity. The metal-free design is cost-effective and can retain the energy density of the Li metal, minimizing the unnecessary energy sacrifice from the extra high gravimetric density lithiophilic sites. The FCF hosted Li delivers a promoted high Coulombic efficiency, homogeneous Li deposition, and ultrahigh rate stable cycling over 1000 cycles at 20 mA cm^-2 with a much lower voltage polarization (≈220 mV). Moreover, half cells coupled with LiNi_0.8 Co_0.1 Mn_0.1 O₂ , sulfur or even thick LiCoO₂ cathode demonstrate superior rate performances and enhanced cycling stability even under a lean electrolyte. This work proves the feasibility of FCF hosted Li for practical usage and provides a novel approach toward cost-effective and high performance lithium metal batteries.

Tafolecimab, a novel potential long-acting PCSK9 monoclonal antibody: efficacy and safety in healthy and hypercholesterolemia subjects

Background

LDL cholesterol (LDL-C) is a well-established risk factor for cardiovascular disease. PCSK9 binds LDL receptors, targeting them for degradation. The dosing intervals for currently available PCSK9 monoclonal antibodies are once every 2 or 4 weeks. Tafolecimab, a novel recombinant human PCSK9 monoclonal antibody, was found to have higher affinity with PCSK9 and show longer LDL-C reduction compared to evolocumab in preclinical studies.

Purposes

The objectives for the SAD and MAD studies were to investigate the safety and efficacy of tafolecimab and explore the optimal dosing schedule.

Methods

The phase 1 study was a randomized, placebo-controlled, double-blind, single-ascending dose study (SAD) in Chinese healthy subjects, who were randomized 3:1 to tafolecimab and placebo (n=58). SAD subjects received tafolecimab subcutaneously at 25/75/150/300/450/600mg, or intravenously at 75/450mg, monitored up to day 84. The phase 2 study was a randomized, double-blind, placebo-controlled, repeated-dosing, multiple ascending dose (MAD) study in patients with hypercholesterolemia, who were randomized 4:1 to tafolecimab and placebo (n=60). MAD subjects received tafolecimab subcutaneously at 75/140mg every 2 weeks, 300/420mg every 4weeks, 450/600mg every 6 weeks up to day 84 or 98 with 3 months follow-up.

Results

In the SAD, the maximum mean reduction in LDL-C ranged from 52.2% to 72.1% and was achieved as early as 5 days (figure 1a). The duration of LDL-C reduction was tafolecimab dose dependent. In the MAD, the mean LDL-C concentrations were reduced by tafolecimab for each dose at 12 weeks relative to baseline (ranging from 54.30% to 72.26%; p<0.001). Particularly, a 56.52% (−72.50%, −40.54%) reduction of LDL-C was observed in the cohort of 600mg Q6W. The effect sustained till week 14 (8 weeks after the last dose) where there was still a 43.46% (−60.96%, −25.96%) reduction from baseline (figure 1b). The mean reduction of Lp(a) at week 12 ranged from 24.04% to 50.59% relative to baseline. Tafolecimab reduced the other lipids when comparing with placebo. The pharmacokinetics/pharmadynamics (LDL-C) profiles of tafolecimab were well characterised and support the potential dosing interval of 6–8 weeks subcutaneously.

Both healthy and hypercholesterolemia subjects are generally tolerable to tafolecimab. Reported treatment-emergent adverse events (TEAEs) were: tafolecimab 23 (52.3%) vs. placebo 8 (57.1%); tafolecimab 34 (70.8%) vs. placebo 9 (75.0%) in the SAD and MAD respectively. There were no serious TEAEs or events leading to death or treatment discontinuation in both SAD and MAD.

Conclusions

Tafolecimab was well tolerated in both healthy and hypercholesterolemia in Chinese subjects, and improved lipid profile including LDL-C, Lp(a) and other lipids. The sustained effects on LDL-C suggests the potential of tafolecimab as a long-lasting PCSK9 inhibitor with dosing interval of 6–8 weeks or beyond.

Figure 1. LDL-C: Percent change from baseline

Funding Acknowledgement

Type of funding source: Private company. Main funding source(s): Innovent Biologics (Suzhou), China

Homologous Strategy to Construct High-Performance Coupling Electrodes for Advanced Potassium-Ion Hybrid Capacitors

Potassium-ion hybrid capacitors (PIHCs) have been considered as promising potentials in mid- to large-scale storage system applications owing to their high energy and power density. However, the process involving the intercalation of K⁺ into the carbonaceous anode is a sluggish reaction, while the adsorption of anions onto the cathode surface is relatively faster, resulting in an inability to exploit the advantage of high energy. To achieve a high-performance PIHC, it is critical to promote the K⁺ insertion/desertion in anodic materials and design suitable cathodic materials matching the anodes. In this study, we propose a facile "homologous strategy" to construct suitable anode and cathode for high-performance PIHCs, that is, unique multichannel carbon fiber (MCCF)-based anode and cathode materials are firstly prepared by electrospinning, and then followed by sulfur doping and KOH activation treatment, respectively. Owing to a multichannel structure with a large interlayer spacing for introducing S in the sulfur-doped multichannel carbon fiber (S-MCCF) composite, it presents high capacity, super rate capability, and long cycle stability as an anode in potassium-ion cells. The cathode composite of activated multichannel carbon fiber (aMCCF) has a considerably high specific surface area of 1445 m² g^-1 and exhibits outstanding capacitive performance. In particular, benefiting from advantages of the fabricated S-MCCF anode and aMCCF cathode by homologous strategy, PIHCs assembled with the unique MCCF-based anode and cathode show outstanding electrochemical performance, which can deliver high energy and power densities (100 Wh kg^-1 at 200 W kg^-1, and 58.3 Wh kg^-1 at 10,000 W kg^-1) and simultaneously exhibit superior cycling stability (90% capacity retention over 7000 cycles at 1.0 A g^-1). The excellent electrochemical performance of the MCCF-based composites for PIHC electrodes combined with their simple construction renders such materials attractive for further in-depth investigations of alkali-ion battery and capacitor applications.

Tailor-Made Gives the Best Fits: Superior Na/K-Ion Storage Performance in Exclusively Confined Red Phosphorus System

As the most promising anodic candidate for alkali ion batteries, red phosphorus (P) still faces big challenges, such as the poor rate and cycling performance, which are caused by the insulative nature and the large volume change throughout the alloy/dealloy process. To ameliorate above issues, the traditional way is confining P into the carbon host. However, investigations on maximizing P utilization are inadequate; in other words, how to achieve entire confinement with a high loading amount is still a problem. Additionally, the application of P in potassium-ion batteries (PIBs) is in its infant stage, and the corresponding potassiation product is controversial. Herein, a nitrogen-doped stripped-graphene CNT (N-SGCNT) as carbon framework is prepared to exclusively confine ultrafine P to construct P@N-SGCNT composites. Benefitting from the in situ cross-linked structure, N-SGCNT loaded with 41.2 wt % P (P₂@N-SGCNT) shows outstanding Na⁺/K⁺ storage performance. For instance, P₂@N-SGCNT exhibits high reversible capacities of 2480 mAh g^-1 for sodium-ion batteries (SIBs) and 762 mAh g^-1 for PIBs, excellent rate capabilities of 1770 mAh g^-1 for SIBs and 354 mAh g^-1 for PIBs at 2.0 A g^-1, and long cycling stability (a capacity of 1936 mAh g^-1 after 2000 cycles for SIBs and 319 mAh g^-1 after 1000 cycles for PIBs). Furthermore, due to this exclusively confined P structure, the K⁺ storage mechanism with the end product of K₄P₃ has been identified by experimental and theoretical results.

LncRNA MALAT1 inhibits osteogenic differentiation of mesenchymal stem cells in osteoporosis rats through MAPK signaling pathway

OBJECTIVE

The aim of this study was to explore whether long non-coding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 (lncRNA MALAT1) could lead to osteoporosis (OP) by stimulating the activation of the mitogen-activated protein kinase (MAPK) signaling pathway.

MATERIALS AND METHODS

The OP model was first successfully established in rats. The expression of lncRNA MALAT1 in OP rats and normal rats was detected via quantitative Polymerase Chain Reaction (qPCR). Bone marrow mesenchymal stem cells (BMSCs) were cultured and transfected to establish the MALAT1 knockdown model. Subsequently, the apoptosis of mesenchymal stem cells in MALAT1 siRNA group and NC siRNA group was detected via flow cytometry. Meanwhile, the expressions of the MAPK signaling pathway proteins related to OP were detected via Western blotting. After alkaline phosphatase (ALP) staining in cells of both groups, early osteogenic differentiation of BMSCs was observed.

RESULTS

The results of qPCR showed that the expression of lncRNA MALAT1 in OP rats was significantly lower than that of normal rats. It was observed under a fluorescence microscope that there were a large number of siRNA particles in BMSCs. The expression of lncRNA MALAT1 in cells was detected via Real Time-fluorescence qPCR as well. The results indicated that siRNA transfection could effectively inhibit the expression of lncRNA MALAT1, indicating successful transfection. Flow cytometry revealed that no significant difference was observed in the apoptosis of BMSCs between the MALAT1 siRNA group and NC siRNA group. Besides, the results of Western blotting showed that the expression levels of the MAPK signaling pathway-related proteins extracellular signal-regulated kinase 1/2 (ERK1/2) and P38 in MALAT1 siRNA group were significantly higher than those of the NC siRNA group. This indicated that inhibiting the expression of lncRNA MALAT1 might promote the activation of the OP-related MAPK pathway. According to the results of ALP staining, the depth of staining in MALAT1 siRNA group was markedly declined when compared with the NC siRNA group. Quantification of ALP activity demonstrated that ALP activity in the MALAT1 siRNA group was markedly declined compared with the NC siRNA group. The above results suggested that suppressing the expression of lncRNA MALAT1 could reduce the ALP activity of BMSCs. Furthermore, lncRNA MALAT1 inhibited osteogenic differentiation of BMSCs.

CONCLUSIONS

LncRNA MALAT1 was lowly expressed in OP rats. Moreover, it inhibited osteogenic differentiation of BMSCs by enhancing the activation of the MAPK signaling pathway, thereby promoting OP progression.

Second harmonic generation microscopy using pixel reassignment

Second harmonic generation (SHG) microscopy is expected to be a powerful tool for observing the cellular-level functionality and morphology information of thick tissue owe to its unique imaging properties. However, the maximum attainable resolution obtainable by SHG microscopy is limited by the use of long-wavelength, near-infrared excitation. In this paper, we report the use of pixel reassignment to improve the spatial resolution of SHG microscopy. The SHG signal is imaged onto a position-sensitive camera, instead of a point detector typically used in conventional SHG microscope. The data processing is performed through pixel reassignment and subsequent deblurring operation. We present the basic principle and a rigorous theoretical model for SHG microscopy using pixel reassignment (SHG-PR). And for the first time, the optimal reassignment factor for SHG-PR is derived based on the coherent characteristics and the dependence of wavelength in SHG microscopy. To evaluate the spatial resolution improvement, images of nano-beads separated by different distances and of a microtubule array have been simulated. We gain about a 1.5-fold spatial resolution enhancement compared to conventional SHG microscopy. When a further deblurring operation is implemented, this method allows for a total spatial resolution enhancement of about 1.87. Additionally, we demonstrate the validity of SHG-PR for raw data with noise. LAY DESCRIPTION: Second harmonic generation (SHG) microscopy has emerged as a powerful imaging technique in clinical diagnostics and biological research. SHG microscopy is label-free and provides intrinsic optical sectioning for three-dimensional (3D) imaging. However, a near-infrared excitation wavelength results a restriction in the maximum attainable spatial resolution of SHG microscopy. In this paper, we present a simple resolution-enhanced SHG imaging method, SHG microscopy using pixel reassignment (SHG-PR). We demonstrate a rigorous theoretical model for SHG-PR and derive the optimal reassignment factor. The simulation result shows the clear improvement of the image resolution and contrast in the SHG-PR after deblurring operation. The FWHM value of single microtubule shows that SHG-PR enables a spatial resolution enhancement by a factor of 1.5, compared to conventional SHG microscopy. After a proper deblurring operation, this method allows for a total spatial resolution enhancement of about 1.87. The improvements of spatial resolution and contrast are still valid for raw data with noise. It is expected that this method can contribute towards new insights in unstained tissue morphology, interaction of cells, and diseases diagnosis.

[Progress of cohort studies in countries from Asia and Europe]

Objective: To share related knowledge and experiences with countries along the line, literature regarding current cohort studies was summarized. Distribution, establishment and development of cohort studies among large prospective general population were analyzed in 17 countries of Western Asia and the 16 countries of Central and Eastern Europe. Methods: Literature review was conducted to collect basic information on cohort studies, with descriptive study used to analyze the characteristics of these cohort studies. Results: There were 562 cohort studies with sample size as more than 1 000 stated in Western Asia and Central and Eastern Europe, including 468 (83.27%) carried out in the nation itself and 94 (16.73%) with international multicentered collaboration. According to the nature of cohort studies, 347 (61.74%) were etiologically based. As for the contents involved, 310 (55.16%) of them targeted on chronic/non-communicable diseases, 125 (22.24%) concentrated on maternal and child health. Among those on chronic/non-communicable diseases, 51 (16.45%) were on cancers and 83 (26.77%) on cardiovascular disease studies. There appeared 10 large prospective cohort studies targeting on general population, mainly ongoing in Iran and European countries, with a duration of 8-29 years, including 4 of them with sample size as more than 50 000. In terms of the contents, epidemiological investigation, physical examination and biological samples collection took the major parts. Few papers were published in 9 out of the 10 cohort studies at the early stage of those projects but the number of papers increased annually and stabilized to certain extent. Conclusions: The regional distribution of cohort studies carried out in countries from the Western Asia and Central and Eastern European areas appeared unbalanced. Contents of these designs would mainly involve etiological studies, with focus on non-communicable diseases as cancer, cardiovascular disease, diabetes, respiratory diseases, mental and psychological diseases, and maternal and infant health etc.. However, only few large prospective cohort studies would base on general population.

Fast and Stable Batteries with High Capacity Enabled by Germanium-Phosphorus Binary Nanoparticles Embedded in a Porous Carbon Matrix via Metallothermic Reduction

Lithium-alloyable materials such as Ge and P have attracted considerable attention as promising anode materials for lithium-ion batteries (LIBs) owing to their high theoretical capacity. However, these materials inevitably undergo capacity attenuation caused by large volume expansion in repeated electrochemical processes. Herein, we propose a facile strategy to synthesize germanium-phosphorus binary nanoparticles embedded in porous carbon (GPBN/C) via metallothermic reduction. As an LIB anode, the GPBN/C electrode exhibits outstanding rate performance (368 mAh g^-1 at 40 A g^-1) and remarkable long-term cycling ability (541 mAh g^-1 at 1.0 A g^-1 after 1000 cycles). Besides, the GPBN/C composite electrode presents an outstanding cycling performance at wide temperature ranges, showing reversible capacities of 1030 and 696 mAh g^-1 at 60 and 0 °C, respectively. Attributed to the formation of highly dispersed Ge-P nanoparticles in a porous carbon matrix, the GPBN/C electrode shows exceptional electrochemical performance. Importantly, our strategy provides an effective way to explore alloy-type electrodes to develop fast and stable high-capacity batteries.

[Changes of urinary monocyte chemotactic protein 1 and epidermal growth factor and their correlations with clinicopathology in idiopathic membranous nephropathy patients]

Objective: To explore the changes and clinical value of urinary monocyte chemotactic protein 1 (MCP-1), epidermal growth factor (EGF) and their ratio in patients with idiopathic membranous nephropathy (IMN). Methods: A total of 67 IMN patients were enrolled according to kidney biopsy in the Department of Nephrology of the First Affiliated Hospital of Zhengzhou University from January 2017 to December 2018. The patients included 28 males and 39 females, with an average age of (47.6±14.2) years. Eighteen age-and sex-matched healthy controls were also enrolled. Clinical and pathological data, blood and urine samples of all subjects were collected. Urinary MCP-1 and EGF level were detected by enzyme-linked immunosorbent assay (ELISA). And then the levels of urinary MCP-1, EGF and the ratio of EGF/MCP-1 and their correlations with clinicopathology were analyzed. Results: There was no statistical difference of the urine EGF levels between the two groups [8.3(6.0,12.6) vs 8.4(6.5,10.2) ng/mg Cr, P=0.575]. The urine MCP-1 levels of IMN patients were 0.37 (0.21, 0.69) ng/mg Cr, which was statistical significantly higher than those of the control group [0.09 (0.02, 0.19) ng/mg Cr] (P<0.001), while the EGF/MCP-1 ratio was lower than that of the control group [22.2(15.1,36.6) vs 87.6(71.2,132.7), P<0.001]. Urine MCP-1 was negatively correlated with eGFR (r=-0.303, P=0.012), but positively correlated with the urinary ratio of albumin to creatinin (r=0.368, P=0.002). EGF was positively correlated with eGFR (r=0.722, P<0.001), but negatively correlated with the severity of interstitial fibrosis and renal tubular atrophy (IFTA) (r=-0.312, P=0.011). EGF/MCP-1 ratio was positively correlated with eGFR (r=0.693, P<0.001), but negatively correlated with the severity of the urinary ratio of albumin to creatinin and IFTA (r=-0.261, P=0.028 and r=-0.684, P<0.001, respectively). Further multivariate logistic regression analysis showed that EGF/MCP-1 was a protective factor for moderate-to-severe IFTA (OR=0.891, 95%CI: 0.844-0.949, P=0.008). Conclusion: Patients with IMN have elevated urine MCP-1 level and decreased EGF/MCP-1 ratio, which correlate with clinical indicators. In particular, EGF/MCP-1 ratio is independently related to moderate-severe IFTA, and may be a potential clinical biomarker for diagnosis of IMN.

Does dual-energy CT differentiate benign and malignant ovarian tumours?

AIM

To assess the ability of dual-energy computed tomography (DECT) to distinguish benign from malignant ovarian tumours (OTs).

MATERIALS AND METHODS

Following approval of the institutional review board, the institutional database was mined for treatment-naive patients who underwent primary cytoreduction for OT. Thirty-seven patients were included and divided into those with benign OTs (n = 11) and malignant OTs (n = 26), including high-grade (n = 20) and low-grade (n = 6) malignant OTs. Advanced processing and region of interest delineation on the ovarian mass were performed using the preoperative staging DECT examination using the Advantage Workstation. The pixel-level data of the CT attenuation values at 50, 70, and 120 keV and the effective atomic number (Z_eff), water content (WC), and iodine content (IC) in the ovarian mass were recorded. The Wilcoxon rank-sum test was used to compare CT attenuation data at different voltages, Z_eff, and WC and IC levels between benign and malignant OTs and between high- and low-grade malignant OTs. Simple logistic regression was used to correlate the imaging characteristics with malignant status and grade.

RESULTS

Malignant OTs had significantly higher Z_eff and IC compared with benign OTs. The threshold values for the diagnosis of malignant OT were IC≥9.74 (100 μg/cm³) with 81% sensitivity and 73% specificity and Z_eff ≥8.16 with 85% sensitivity and 73% specificity. High-grade OTs had significantly higher WC compared with low-grade OTs, and a threshold of ≥1,013.92 mg/cm³ differentiated them with 80% sensitivity and 83% specificity.

CONCLUSION

DECT may be a tool to help distinguish malignant and benign OTs and predict tumour grade.

20-Hydroxyecdysone receptor-activated Bombyx mori CCAAT/enhancer-binding protein gamma regulates the expression of BmCBP and subsequent histone H3 lysine 27 acetylation in Bo. mori

Cyclic adenosine monophosphate (cAMP) response element binding protein (CREB)-binding protein (CBP or CREBBP) plays important roles in regulating gene transcription and animal development. However, the process by which CBP is up-regulated to impact insect development is unknown. In this study, the regulatory mechanism of Bombyx mori CBP (BmCBP) expression induced by 20-hydroxyecdysone (20E) was investigated. In the Bo. mori cell line, DZNU-Bm-12, 20E enhanced BmCBP transcription and histone H3K27 acetylation. BmCBP RNA interference (RNAi) resulted in decreased histone H3K27 acetylation. Additionally, the luciferase activity analysis revealed that the transcription factor, Bo. mori CCAAT/enhancer-binding protein gamma (BmC/EBPg), activated BmCBP transcription, which was suppressed by BmC/EBPg RNAi and promoted by BmC/EBPg overexpression. Electrophoretic mobility shift assay and chromatin immunoprecipitation results demonstrated that BmC/EBPg could bind to the C/EBP cis-regulatory elements in two positions of the BmCBP promoter. Moreover, BmC/EBPg transcription was enhanced by the 20E receptor (BmEcR), which bound to the BmC/EBPg promoter. BmEcR RNAi significantly inhibited the transcriptional levels of BmC/EBPg and BmCBP in the presence of 20E. Furthermore, the BmEcR-BmC/EBPg pathway regulated the acetylation levels of histone H3K27. Altogether, these results indicate that BmEcR enhances the expression of BmC/EBPg, which binds to the BmCBP promoter, activates BmCBP expression and leads to histone H3K27 acetylation.

Estimation of error variance via ridge regression

We propose a novel estimator of error variance and establish its asymptotic properties based on ridge regression and random matrix theory. The proposed estimator is valid under both low- and high-dimensional models, and performs well not only in nonsparse cases, but also in sparse ones. The finite-sample performance of the proposed method is assessed through an intensive numerical study, which indicates that the method is promising compared with its competitors in many interesting scenarios.

A modified ‘skeleton/skin’ strategy for designing CoNiP nanosheets arrayed on graphene foam for on/off switching of NaBH4 hydrolysis

CoNiP nanosheet array catalysts were successfully prepared on three-dimensional (3D) graphene foam using hydrothermal synthesis. These catalysts were prepared using 3D Ni–graphene foam (Ni/GF), comprising nickel foam as the ‘skeleton’ and reduced graphene oxide as the ‘skin’. This unique continuous modified ‘skeleton/skin’ structure ensure that the catalysts had a large surface area, excellent conductivity, and sufficient surface functional groups, which promoted in situ CoNiP growth, while also optimizing the hydrolysis of sodium borohydride. The nanosheet arrays were fully characterized and showed excellent catalytic performance, as supported by density functional theory calculations. The hydrogen generation rate and activation energy are 6681.34 mL min⁻¹ g⁻¹ and 31.2 kJ mol⁻¹, respectively, outperforming most reported cobalt-based catalysts and other precious metal catalysts. Furthermore, the stability of mockstrawberry-like CoNiP catalyst was investigated, with 74.9% of the initial hydrogen generation rate remaining after 15 cycles. The catalytic properties, durability, and stability of the catalyst were better than those of other catalysts reported previously.

Schematic diagram of the preparation, cycles and the kinetics of the Ni/GF/CoNiP nanosheet catalyst.